{"DataElement":{"publicId":"5526485","version":"1","preferredName":"Autoimmune Disease PostBMT Response Category","preferredDefinition":"Identification of the status of active autoimmune issues post bone marrow transplantation.","longName":"AUT_POST_BMT_RES_CAT","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"5526480","version":"1","preferredName":"Active Autoimmune Disease Timepoint Post Transplantation Disease Response","preferredDefinition":"A specific point in the time continuum, including those established relative to an event._Happening at a time subsequent to a reference time; later in time or order._Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species._The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._Exerting influence or producing an effect; taking part in an activity._A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).","longName":"5526478v1.0:5525883v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"5526478","version":"1","preferredName":"Active Autoimmune Disease","preferredDefinition":"Exerting influence or producing an effect; taking part in an activity.:A condition in which the body recognizes its own tissues as foreign and directs an immune response against them.","longName":"C45329:C2889","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Active","conceptCode":"C45329","definition":"Exerting influence or producing an effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Autoimmune Disease","conceptCode":"C2889","definition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F28BA8F-F0B0-2A50-E053-F662850AF762","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"ONEDATA","dateModified":"2016-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5525883","version":"1","preferredName":"Timepoint Post Transplantation Disease Response","preferredDefinition":"A specific point in the time continuum, including those established relative to an event.:Happening at a time subsequent to a reference time; later in time or order.:Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.:The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","longName":"C68568:C38008:C15342:C50995","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Timepoint","conceptCode":"C68568","definition":"A specific point in the time continuum, including those established relative to an event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F27A5BA-2AFC-6999-E053-F662850A8C54","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"ONEDATA","dateModified":"2016-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F28BA8F-F0BE-2A50-E053-F662850AF762","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeDescription":"Curated to support NCI CCR Primary Immunosuppression CRF template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5526470","version":"1","preferredName":"Autoimmune Disease PostBMT Response Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"AUTOIM_BMT_RESP_CAT","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"80","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Active autoimmune issues with no further intervention","valueDescription":"Active Without Further Intervention or Procedure Autoimmune Disease","ValueMeaning":{"publicId":"5526471","version":"1","preferredName":"Active Without Further Intervention or Procedure Autoimmune Disease","longName":"5526471","preferredDefinition":"Exerting influence or producing an effect; taking part in an activity.: Used to indicate the absence or lack of something or someone.: To or at a greater distance in time or space.: An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.: A condition in which the body recognizes its own tissues as foreign and directs an immune response against them.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Active","conceptCode":"C45329","definition":"Exerting influence or producing an effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Further","conceptCode":"C25519","definition":"To or at a greater distance in time or space.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Autoimmune Disease","conceptCode":"C2889","definition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F288B8C-2147-133B-E053-F662850AF106","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F288B8C-2160-133B-E053-F662850AF106","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"ONEDATA","dateModified":"2016-10-18","deletedIndicator":"No"},{"value":"Active autoimmune issues despite further intervention","valueDescription":"Active With Further Intervention or Procedure Immune Disease","ValueMeaning":{"publicId":"5526472","version":"1","preferredName":"Active With Further Intervention or Procedure Immune Disease","longName":"5526472","preferredDefinition":"Exerting influence or producing an effect; taking part in an activity.: Used to indicate the presence of something or someone.: To or at a greater distance in time or space.: An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.: A disorder resulting from an abnormality in the immune system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Active","conceptCode":"C45329","definition":"Exerting influence or producing an effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Further","conceptCode":"C25519","definition":"To or at a greater distance in time or space.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immune System Disorder","conceptCode":"C3507","definition":"A disorder resulting from an abnormality in the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F288B8C-2170-133B-E053-F662850AF106","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F288B8C-2189-133B-E053-F662850AF106","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"ONEDATA","dateModified":"2016-10-18","deletedIndicator":"No"},{"value":"Resolved with further intervention","valueDescription":"Physiologic Resolution With Further Intervention or Procedure Autoimmune Disease","ValueMeaning":{"publicId":"5526473","version":"1","preferredName":"Physiologic Resolution With Further Intervention or Procedure Autoimmune Disease","longName":"5526473","preferredDefinition":"Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.: Used to indicate the presence of something or someone.: To or at a greater distance in time or space.: An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.: A condition in which the body recognizes its own tissues as foreign and directs an immune response against them.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Physiologic Resolution","conceptCode":"C25655","definition":"Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Further","conceptCode":"C25519","definition":"To or at a greater distance in time or space.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Autoimmune Disease","conceptCode":"C2889","definition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F288B8C-2199-133B-E053-F662850AF106","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F288B8C-21B2-133B-E053-F662850AF106","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"ONEDATA","dateModified":"2016-10-18","deletedIndicator":"No"},{"value":"Resolved without further resolution","valueDescription":"Physiologic Resolution Without Further Intervention or Procedure Autoimmune Disease","ValueMeaning":{"publicId":"5526474","version":"1","preferredName":"Physiologic Resolution Without Further Intervention or Procedure Autoimmune Disease","longName":"5526474","preferredDefinition":"Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.: Used to indicate the absence or lack of something or someone.: To or at a greater distance in time or space.: An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.: A condition in which the body recognizes its own tissues as foreign and directs an immune response against them.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Physiologic Resolution","conceptCode":"C25655","definition":"Return to the normal structure and/or function, e.g. the subsidence of a pathologic process, as the subsidence of an inflammatory lesion or new growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Further","conceptCode":"C25519","definition":"To or at a greater distance in time or space.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intervention or Procedure","conceptCode":"C25218","definition":"An activity that produces an effect, or that is intended to alter the course of a disease in a patient or population. This is a general term that encompasses the medical, social, behavioral, and environmental acts that can have preventive, therapeutic, or palliative effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Autoimmune Disease","conceptCode":"C2889","definition":"A disorder resulting from loss of function or tissue destruction of an organ or multiple organs, arising from humoral or cellular immune responses of the individual to his own tissue constituents. It may be systemic (e.g., systemic lupus erythematosus), or organ specific, (e.g., thyroiditis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F288B8C-21C2-133B-E053-F662850AF106","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F288B8C-21DB-133B-E053-F662850AF106","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"ONEDATA","dateModified":"2016-10-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F288B8C-212E-133B-E053-F662850AF106","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeDescription":"Curated to support NCI CCR Primary Immunodeficiency CRF Template.  Value sets are prescribed for that specific set of requirements.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Resolution after BMT","type":"Preferred Question Text","description":"Resolution after BMT","url":null,"context":"CCR"}],"origin":"C3D:Central Cancer Clinical Database","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"3F28BA8F-F0D2-2A50-E053-F662850AF762","latestVersionIndicator":"Yes","beginDate":"2016-10-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-18","modifiedBy":"REEVESD","dateModified":"2016-10-21","changeDescription":"Curated to support NCI CCR Primary Immunosuppression CFR Template.10.21.2016.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}